Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 
Bank of Japan Signals Readiness for Near-Term Rate Hike as Inflation Nears Target 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Asian Currencies Stay Rangebound as Yen Firms on Intervention Talk 
U.S. Stock Futures Rise as Markets Brace for Jobs and Inflation Data 
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal 
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market 
Australian Household Spending Dips in December as RBA Tightens Policy 
Barry Callebaut has halted manufacturing operations at its Weize chocolate plant in Belgium as a precautionary measure while conducting its root cause analysis and risk assessment after detecting salmonella in a production lot.
The company identified lecithin as the source of the contamination.
All chocolate products manufactured at the facility since June 25 have been placed on hold.
After the analysis, the lines will be cleaned and sanitized before production can resume.
Barry Callebaut, which informed the Belgian food authorities (FAVV) about the incident, said that their robust food safety programs allowed them to identify lecithin as the source of the contamination quickly.
The company added that they are reaching out to all customers who may have received impacted products.
The news comes after Ferrero temporarily suspended production at its Arlon facility in Belgium after the site was linked to a salmonella outbreak.
